158 related articles for article (PubMed ID: 36478589)
21. In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease.
Cheng AJT; Macalino SJY; Billones JB; Balolong MP; Murao LAE; Carrillo MCO
J Mol Model; 2022 Oct; 28(11):345. PubMed ID: 36205801
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the effects of chlorhexidine and several flavonoids as antiviral purposes on SARS-CoV-2 main protease: molecular docking, molecular dynamics simulation studies.
Tatar G; Salmanli M; Dogru Y; Tuzuner T
J Biomol Struct Dyn; 2022 Oct; 40(17):7656-7665. PubMed ID: 33749547
[TBL] [Abstract][Full Text] [Related]
24. Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease in Vitro.
Kiba Y; Tanikawa T; Kitamura M
Biol Pharm Bull; 2024; 47(5):965-966. PubMed ID: 38763750
[TBL] [Abstract][Full Text] [Related]
25. Depicting the inhibitory potential of polyphenols from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2022 Jun; 40(9):4110-4121. PubMed ID: 33292085
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.
Tumskiy RS; Tumskaia AV; Klochkova IN; Richardson RJ
Comput Biol Med; 2023 Feb; 153():106449. PubMed ID: 36586228
[TBL] [Abstract][Full Text] [Related]
27. An
Clemente CM; Freiberger MI; Ravetti S; Beltramo DM; Garro AG
J Biomol Struct Dyn; 2022 Aug; 40(12):5653-5664. PubMed ID: 33459192
[TBL] [Abstract][Full Text] [Related]
28. Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2.
Patel D; Athar M; Jha PC
J Biomol Struct Dyn; 2022 Apr; 40(7):3071-3081. PubMed ID: 33200683
[TBL] [Abstract][Full Text] [Related]
29. Understanding the binding mechanism for potential inhibition of SARS-CoV-2 Mpro and exploring the modes of ACE2 inhibition by hydroxychloroquine.
Choudhury M; Dhanabalan AK; Goswami N
J Cell Biochem; 2022 Feb; 123(2):347-358. PubMed ID: 34741481
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach.
El Bakri Y; Anouar EH; Ahmad S; Nassar AA; Taha ML; Mague JT; El Ghayati L; Essassi EM
Appl Biochem Biotechnol; 2021 Nov; 193(11):3602-3623. PubMed ID: 34324152
[TBL] [Abstract][Full Text] [Related]
31. Interaction of Laurusides 1 and 2 with the 3C-like Protease (M
Autiero I; Roviello GN
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982585
[No Abstract] [Full Text] [Related]
32. Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro.
Swain SS; Singh SR; Sahoo A; Panda PK; Hussain T; Pati S
Proteins; 2022 Sep; 90(9):1617-1633. PubMed ID: 35384056
[TBL] [Abstract][Full Text] [Related]
33. Novel cyclohexanone compound as a potential ligand against SARS-CoV-2 main-protease.
Basu S; Veeraraghavan B; Ramaiah S; Anbarasu A
Microb Pathog; 2020 Dec; 149():104546. PubMed ID: 33011363
[TBL] [Abstract][Full Text] [Related]
34. In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV.
Chunduru K; Sankhe R; Begum F; Sodum N; Kumar N; Kishore A; Shenoy RR; Rao CM; Saravu K
Med Chem; 2021; 17(4):380-395. PubMed ID: 32720605
[TBL] [Abstract][Full Text] [Related]
35. Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease.
Wei W; Kong N; Liu MZ; Han T; Xu JF; Liu C
Biochem Biophys Res Commun; 2022 Aug; 616():8-13. PubMed ID: 35636257
[TBL] [Abstract][Full Text] [Related]
36. Large scale peptide screening against main protease of SARS CoV-2.
Uddin MJ; Akhter H; Chowdhury U; Mawah J; Karim ST; Jomel M; Islam MS; Islam MR; Onin LAB; Ali MA; Efaz FM; Halim MA
J Comput Chem; 2023 Mar; 44(8):887-901. PubMed ID: 36478400
[TBL] [Abstract][Full Text] [Related]
37. Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, M
Naidoo D; Kar P; Roy A; Mutanda T; Bwapwa J; Sen A; Anandraj A
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500548
[TBL] [Abstract][Full Text] [Related]
38.
Alesawy MS; Elkaeed EB; Alsfouk AA; Metwaly AM; Eissa IH
Molecules; 2021 Oct; 26(21):. PubMed ID: 34771004
[TBL] [Abstract][Full Text] [Related]
39. Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations.
Ahmad B; Batool M; Ain QU; Kim MS; Choi S
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502033
[TBL] [Abstract][Full Text] [Related]
40. Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies.
Kumar S; Sharma PP; Upadhyay C; Kempaiah P; Rathi B; Poonam
Methods; 2021 Nov; 195():44-56. PubMed ID: 33639316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
